SEEBRI BREEZHALER 44 microgrammes, poudre pour inhalation en gélule — 10 plaquette(s) polyamide aluminium PVC-Aluminium de 1 gélule(s) avec inhalateur(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930021026 -
CIP7
3002102 -
CIS
69941269 -
Registration number
EU/1/12/788
What the source publishes
- Holder
- NOVARTIS EUROPHARM (IRLANDE)
- Active ingredients
- BROMURE DE GLYCOPYRRONIUM, GLYCOPYRRONIUM
- Form
- poudre pour inhalation en gélule
- Package
- 10 plaquette(s) polyamide aluminium PVC-Aluminium de 1 gélule(s) avec inhalateur(s)
- Routes
- inhalée
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration d'arrêt de commercialisation
- Authorised on
- 2012-09-28
- Prescription
- Prescription or restricted
Names this record is found by
- SEEBRI BREEZHALER 44 microgrammes, poudre pour inhalation en gélule — 10 plaquette(s) polyamide aluminium PVC-Aluminium de 1 gélule(s) avec inhalateur(s)
- SEEBRI BREEZHALER 44 microgrammes, poudre pour inhalation en gélule
- BROMURE DE GLYCOPYRRONIUM
- GLYCOPYRRONIUM
Complete source data
{
"cis": "69941269",
"cip7": "3002102",
"form": "poudre pour inhalation en gélule",
"name": "SEEBRI BREEZHALER 44 microgrammes, poudre pour inhalation en gélule — 10 plaquette(s) polyamide aluminium PVC-Aluminium de 1 gélule(s) avec inhalateur(s)",
"cip13": "3400930021026",
"holder": "NOVARTIS EUROPHARM (IRLANDE)",
"routes": [
"inhalée"
],
"holders": [
"NOVARTIS EUROPHARM (IRLANDE)"
],
"currency": "EUR",
"marketed": false,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2012-09-28",
"compositions": [
{
"name": "BROMURE DE GLYCOPYRRONIUM",
"nature": "SA",
"strength": "63 microgrammes",
"linkageNumber": "1",
"substanceCode": "03850",
"dosageReference": "une gélule",
"pharmaceuticalElement": "poudre"
},
{
"name": "GLYCOPYRRONIUM",
"nature": "FT",
"strength": "50 microgrammes",
"linkageNumber": "1",
"substanceCode": "20884",
"dosageReference": "une gélule",
"pharmaceuticalElement": "poudre"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "SEEBRI BREEZHALER 44 microgrammes, poudre pour inhalation en gélule",
"marketingStatus": "Déclaration d'arrêt de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "10 plaquette(s) polyamide aluminium PVC-Aluminium de 1 gélule(s) avec inhalateur(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2026-01-05",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"BROMURE DE GLYCOPYRRONIUM",
"GLYCOPYRRONIUM"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/12/788",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930021026"